Nath Bio-Genes (India) Limited (NATHBIOGEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.160x

Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has a cash flow conversion efficiency ratio of -0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.09 Billion ≈ $-11.75 Million USD) by net assets (Rs6.80 Billion ≈ $73.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Nath Bio-Genes (India) Limited (NATHBIOGEN) balance sheet quality index to measure how much of total assets are equity-financed.

Nath Bio-Genes (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2026)

This chart illustrates how Nath Bio-Genes (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Nath Bio-Genes (India) Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Nath Bio-Genes (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
K Way Information TWO:5201	-0.031x
Bluglass Ltd AU:BLG	0.000x
Kekrops S.A. AT:KEKR	-0.005x
Templeton Emerging Markets Investment Trust TEMIT LSE:TEM	0.003x
Stampede Drilling Inc V:SDI	0.070x
Dental Corporation Public Company Limited BK:D	0.064x
Y-S Electronic Co Ltd TWO:6418	0.020x
Pioneer Power Solutions Inc. NASDAQ:PPSI	-0.033x

Annual Cash Flow Conversion Efficiency for Nath Bio-Genes (India) Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2026. For the full company profile with market capitalisation and key ratios, see Nath Bio-Genes (India) Limited (NATHBIOGEN) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs6.80 Billion ≈ $73.59 Million	Rs-220.35 Million ≈ $-2.38 Million	-0.032x	-218.69%
2025-03-31	Rs6.44 Billion ≈ $69.69 Million	Rs175.81 Million ≈ $1.90 Million	0.027x	-72.93%
2024-03-31	Rs6.10 Billion ≈ $65.96 Million	Rs614.80 Million ≈ $6.65 Million	0.101x	+50.59%
2023-03-31	Rs5.73 Billion ≈ $61.99 Million	Rs383.67 Million ≈ $4.15 Million	0.067x	+112.82%
2022-03-31	Rs5.42 Billion ≈ $58.61 Million	Rs170.46 Million ≈ $1.84 Million	0.031x	+1633.30%
2021-03-31	Rs6.13 Billion ≈ $66.32 Million	Rs11.13 Million ≈ $120.35K	0.002x	-89.32%
2020-03-31	Rs5.58 Billion ≈ $60.30 Million	Rs94.74 Million ≈ $1.02 Million	0.017x	+139.22%
2019-03-31	Rs5.08 Billion ≈ $54.89 Million	Rs-219.89 Million ≈ $-2.38 Million	-0.043x	+56.74%
2018-03-31	Rs4.69 Billion ≈ $50.75 Million	Rs-469.84 Million ≈ $-5.08 Million	-0.100x	-512.04%
2017-03-31	Rs1.38 Billion ≈ $14.88 Million	Rs33.43 Million ≈ $361.58K	0.024x	+120.81%
2016-03-31	Rs1.21 Billion ≈ $13.12 Million	Rs-141.68 Million ≈ $-1.53 Million	-0.117x	-285.23%
2015-03-31	Rs1.07 Billion ≈ $11.59 Million	Rs67.55 Million ≈ $730.58K	0.063x	-65.69%
2014-03-31	Rs817.78 Million ≈ $8.84 Million	Rs150.28 Million ≈ $1.63 Million	0.184x	-25.68%
2013-03-31	Rs574.74 Million ≈ $6.22 Million	Rs142.11 Million ≈ $1.54 Million	0.247x	--

About Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN India Agricultural Inputs

Market Cap

$32.64 Million

Rs3.02 Billion INR

Market Cap Rank

#23426 Global

#1299 in India

Share Price

Rs158.84

Change (1 day)

-0.21%

52-Week Range

Rs129.02 - Rs196.01

All Time High

Rs537.81